Search research articles
Contact Us
Filters
Showing results (441-450 of 493) with videos related to
Page
of 50
Sort By:
Archives of Neurology
|
November 13, 2008
Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale
Rohit Bakshi, Mohit Neema, Brian C Healy, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
|
November 6, 2009
Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis
James M Stankiewicz, Bonnie I Glanz, Brian C Healy, et al.
Journal of the Neurological Sciences
|
January 3, 2012
Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: a longitudinal study
Jennifer Moodie, Brian C Healy, Guy J Buckle, et al.
The Journal of Head Trauma Rehabilitation
|
September 27, 2024
Cognitive Performance is Associated With 1-Year Participation and Life Satisfaction Outcomes: A Traumatic Brain Injury Model Systems Study
Natalie Gilmore, Thomas F Bergquist, Jennifer Bogner, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
January 17, 2022
Serum NfL levels in the first five years predict 10-year thalamic fraction in patients with MS
Hrishikesh Lokhande, Mattia Rosso, Shahamat Tauhid, et al.
Organic & Biomolecular Chemistry
|
December 11, 2014
Synthesis and antimalarial evaluation of amide and urea derivatives based on the thiaplakortone A natural product scaffold
Brett D Schwartz, Tina S Skinner-Adams, Katherine T Andrews, et al.
The Journal of Clinical Investigation
|
March 17, 2022
microRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balance
Mai Fujiwara, Radhika Raheja, Lucien P Garo, et al.
European Journal of Applied Physiology
|
August 30, 2018
Effect of 1-week betalain-rich beetroot concentrate supplementation on cycling performance and select physiological parameters
Petey W Mumford, Wesley C Kephart, Matthew A Romero, et al.
Neurology
|
August 18, 2010
HLA B*44: protective effects in MS susceptibility and MRI outcome measures
B C Healy, M Liguori, D Tran, et al.
JAMA Neurology
|
January 24, 2017
Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity
Keren Regev, Brian C Healy, Fariha Khalid, et al.
Page
of 50
Search research articles
Search
Showing results (441-450 of 493) with videos related to
Sort By:
Page
of 50
Archives of Neurology
|
November 13, 2008
Predicting clinical progression in multiple sclerosis with the magnetic resonance disease severity scale
Rohit Bakshi, Mohit Neema, Brian C Healy, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
|
November 6, 2009
Brain MRI lesion load at 1.5T and 3T versus clinical status in multiple sclerosis
James M Stankiewicz, Bonnie I Glanz, Brian C Healy, et al.
Journal of the Neurological Sciences
|
January 3, 2012
Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: a longitudinal study
Jennifer Moodie, Brian C Healy, Guy J Buckle, et al.
The Journal of Head Trauma Rehabilitation
|
September 27, 2024
Cognitive Performance is Associated With 1-Year Participation and Life Satisfaction Outcomes: A Traumatic Brain Injury Model Systems Study
Natalie Gilmore, Thomas F Bergquist, Jennifer Bogner, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
January 17, 2022
Serum NfL levels in the first five years predict 10-year thalamic fraction in patients with MS
Hrishikesh Lokhande, Mattia Rosso, Shahamat Tauhid, et al.
Organic & Biomolecular Chemistry
|
December 11, 2014
Synthesis and antimalarial evaluation of amide and urea derivatives based on the thiaplakortone A natural product scaffold
Brett D Schwartz, Tina S Skinner-Adams, Katherine T Andrews, et al.
The Journal of Clinical Investigation
|
March 17, 2022
microRNA-92a promotes CNS autoimmunity by modulating the regulatory and inflammatory T cell balance
Mai Fujiwara, Radhika Raheja, Lucien P Garo, et al.
European Journal of Applied Physiology
|
August 30, 2018
Effect of 1-week betalain-rich beetroot concentrate supplementation on cycling performance and select physiological parameters
Petey W Mumford, Wesley C Kephart, Matthew A Romero, et al.
Neurology
|
August 18, 2010
HLA B*44: protective effects in MS susceptibility and MRI outcome measures
B C Healy, M Liguori, D Tran, et al.
JAMA Neurology
|
January 24, 2017
Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity
Keren Regev, Brian C Healy, Fariha Khalid, et al.
Page
of 50